Dintsios, C. M., & Beinhauer, I. (2020). The impact of additive or substitutive clinical study design on the negotiated reimbursement for oncology pharmaceuticals after early benefit assessment in Germany. BMC.
Citação norma ChicagoDintsios, C. M., and I. Beinhauer. The Impact of Additive or Substitutive Clinical Study Design On the Negotiated Reimbursement for Oncology Pharmaceuticals After Early Benefit Assessment in Germany. BMC, 2020.
Deismireacht MLADintsios, C. M., and I. Beinhauer. The Impact of Additive or Substitutive Clinical Study Design On the Negotiated Reimbursement for Oncology Pharmaceuticals After Early Benefit Assessment in Germany. BMC, 2020.
Rabhadh: D'fhéadfadh nach mbeadh na deismireachtaí seo 100% cruinn i gcónaí.